Does ADALIMUMAB Cause Hyperkeratosis? 332 Reports in FDA Database

Q: Does ADALIMUMAB cause Hyperkeratosis?

332 reports of Hyperkeratosis have been filed with the FDA for ADALIMUMAB, representing 0.1% of all ADALIMUMAB adverse event reports.

Q: How dangerous is Hyperkeratosis from ADALIMUMAB?

Of 332 reports, 4 (1.2%) resulted in death and 80 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 332 reports of Hyperkeratosis have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.

332

Reports of Hyperkeratosis with ADALIMUMAB

0.1%

of all ADALIMUMAB reports

Deaths

Hospitalizations

How Dangerous Is Hyperkeratosis From ADALIMUMAB?

Of the 332 reports, 4 (1.2%) resulted in death, 80 (24.1%) required hospitalization.

Is Hyperkeratosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 332 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Hyperkeratosis?

CABOZANTINIB S-MALATE (411) SUNITINIB MALATE (170) ETANERCEPT (168) SORAFENIB (150) METHOTREXATE (149) VEMURAFENIB (145) REGORAFENIB (136) RIPRETINIB (124) RITUXIMAB (121) TOCILIZUMAB (103)

Which ADALIMUMAB Alternatives Have Lower Hyperkeratosis Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

ADALIMUMAB Full Profile All Hyperkeratosis Reports All Drugs Causing Hyperkeratosis ADALIMUMAB Demographics